-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PZ3VpgrZcIUfy4mKF4uV+zUdKhbzVm3oa24xcp5882bUmdJBD5XxOgZTeHWCjpn/ fgIJvUFMZL8rhAKCCE/0BQ== 0001047469-98-035376.txt : 19980925 0001047469-98-035376.hdr.sgml : 19980925 ACCESSION NUMBER: 0001047469-98-035376 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 19980923 ITEM INFORMATION: ITEM INFORMATION: FILED AS OF DATE: 19980924 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: NORLAND MEDICAL SYSTEMS INC CENTRAL INDEX KEY: 0000946428 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 061387931 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 000-26206 FILM NUMBER: 98714224 BUSINESS ADDRESS: STREET 1: 106 CORPORATE PARK DRIVE STREET 2: SUITE 106 CITY: WHITE PLAINS STATE: NY ZIP: 10604 BUSINESS PHONE: 914-694-2285 MAIL ADDRESS: STREET 1: 106 CORPORATE PARK DRIVE STREET 2: SUITE 106 CITY: WHITE PLAINS STATE: NY ZIP: 10604 FORMER COMPANY: FORMER CONFORMED NAME: OSTECH INC DATE OF NAME CHANGE: 19950608 8-K 1 FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 23, 1998 ------------------------------ NORLAND MEDICAL SYSTEMS, INC. - -------------------------------------------------------------------------------- (Exact name of registrant as specified in its charter) Delaware 0-26206 06-1387931 - -------------------------------------------------------------------------------- (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) 106 Corporate Park Drive, Suite 106, White Plains, NY 10604 - -------------------------------------------------------------------------------- (Address of principal executive offices (Zip Code) Registrant's telephone number, including area code: (914) 694-2285 ---------------------------- ITEM 5. Other Events On September 23, 1998, the Registrant was informed by Nasdaq that the Registrant's Common Stock was delisted from The Nasdaq Stock Market effective with the close of business September 23, 1998. On September 24, 1998, the Registrant issued a press release with respect to such delisting. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein. ITEM 7. Financial Statements and Exhibits Exhibit 99.1. Press release dated September 24, 1998. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NORLAND MEDICAL SYSTEMS, INC. Date: September 24, 1998 By: /s/ Kurt W. Streams ----------------------------------------- Kurt W. Streams Vice President, Finance and Secretary EX-99.1 2 PRESS RELEASE EXHIBIT 99.1 Company Contact: Investor Relations Contact: NORLAND MEDICAL SYSTEMS, INC. LIPPERT/HEILSHORN & ASSOCIATES Kurt Streams Bruce Voss 310-575-4848 Vice President, Finance Kim Golodetz 212-838-3777 914-694-2285 NORLAND MEDICAL SYSTEMS, INC. ANNOUNCES NASDAQ DELISTING WHITE PLAINS, NY, SEPTEMBER 24, 1998 -- NORLAND MEDICAL SYSTEMS, INC. today announced that it received notification from The Nasdaq Stock Market, Inc. that the Company's common stock was delisted from The Nasdaq Stock Market effective with the close of business September 23, 1998. The Company's shares previously traded on the Nasdaq National Market under the symbol NRLD. Norland Medical Systems, Inc. develops, manufactures, sells and services a wide range of bone densitometers used to assess bone mineral content and density, one of several factors used by physicians to aid in the diagnosis and monitoring of bone disorders, particularly osteoporosis. Osteoporosis is a disease that affects more than 25 million Americans, 80% of whom are women. Driven by the availability of new treatments for bone-related disorders, Norland is focusing on bringing affordable, state-of-the-art diagnostic technology directly into the physician's office in order to address a number of women's healthcare problems. The Company also has rights to distribute medical diagnostic products developed by Stratec Medizintechnik GmbH and IMRO Medical Systems. -----END PRIVACY-ENHANCED MESSAGE-----